Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N JONES

Showing results (431-440 of 945) with videos related to

Pageof 95
Sort By:
Diagnostic Microbiology and Infectious Disease|March 1, 1996
Multi-center validation of proposed disk diffusion susceptibility testing interpretive criteria for lomefloxacin using more than 1,500 clinical isolatesM G Cormican, M S Erwin, R N Jones
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2005
Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centresA C Gales, H S Sader, R N Jones
Diagnostic Microbiology and Infectious Disease|January 1, 1995
Cross-resistance analysis for DU-6859a, a new fluoroquinolone, compared to six structurally similar compounds (ciprofloxacin, clinafloxacin, fleroxacin, levofloxacin, ofloxacin, and sparfloxacin)M G Cormican, S A Marshall, R N Jones
Diagnostic Microbiology and Infectious Disease|September 1, 1992
In vitro activity of mersacidin (M87-1551), an investigational peptide antibiotic tested against gram-positive bloodstream isolatesM S Barrett, R P Wenzel, R N Jones
Journal of Chemotherapy (Florence, Italy)|November 26, 2008
Frequency of occurrence and daptomycin susceptibility rates of Gram-positive organisms causing bloodstream infections in cancer patientsH S Sader, T R Fritsche, R N Jones
The Journal of Antimicrobial Chemotherapy|February 10, 2007
Comment on: Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitalsT R Walsh, M A Toleman, R N Jones
Antimicrobial Agents and Chemotherapy|March 1, 1991
Activities of two new teicoplanin amide derivatives (MDL 62211 and MDL 62873) compared with activities of teicoplanin and vancomycin against 800 recent staphylococcal isolates from France and the United StatesR N Jones, F W Goldstein, X Y Zhou
Journal of Clinical Microbiology|November 1, 1989
Reassessment of susceptibility test interpretive criteria for ticarcillin and ticarcillin-clavulanic acidP C Fuchs, R N Jones, A L Barry
Antimicrobial Agents and Chemotherapy|February 1, 1997
In vitro activity and spectrum of LY333328, a novel glycopeptide derivativeR N Jones, M S Barrett, M E Erwin
Diagnostic Microbiology and Infectious Disease|February 1, 1995
Emerging multiply resistant enterococci among clinical isolates. II. Validation of the etest to recognize glycopeptide-resistant strainsR N Jones, M E Erwin, S C Anderson
Pageof 95

Showing results (431-440 of 945) with videos related to

Sort By:
Pageof 95
Diagnostic Microbiology and Infectious Disease|March 1, 1996
Multi-center validation of proposed disk diffusion susceptibility testing interpretive criteria for lomefloxacin using more than 1,500 clinical isolatesM G Cormican, M S Erwin, R N Jones
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2005
Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centresA C Gales, H S Sader, R N Jones
Diagnostic Microbiology and Infectious Disease|January 1, 1995
Cross-resistance analysis for DU-6859a, a new fluoroquinolone, compared to six structurally similar compounds (ciprofloxacin, clinafloxacin, fleroxacin, levofloxacin, ofloxacin, and sparfloxacin)M G Cormican, S A Marshall, R N Jones
Diagnostic Microbiology and Infectious Disease|September 1, 1992
In vitro activity of mersacidin (M87-1551), an investigational peptide antibiotic tested against gram-positive bloodstream isolatesM S Barrett, R P Wenzel, R N Jones
Journal of Chemotherapy (Florence, Italy)|November 26, 2008
Frequency of occurrence and daptomycin susceptibility rates of Gram-positive organisms causing bloodstream infections in cancer patientsH S Sader, T R Fritsche, R N Jones
The Journal of Antimicrobial Chemotherapy|February 10, 2007
Comment on: Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitalsT R Walsh, M A Toleman, R N Jones
Antimicrobial Agents and Chemotherapy|March 1, 1991
Activities of two new teicoplanin amide derivatives (MDL 62211 and MDL 62873) compared with activities of teicoplanin and vancomycin against 800 recent staphylococcal isolates from France and the United StatesR N Jones, F W Goldstein, X Y Zhou
Journal of Clinical Microbiology|November 1, 1989
Reassessment of susceptibility test interpretive criteria for ticarcillin and ticarcillin-clavulanic acidP C Fuchs, R N Jones, A L Barry
Antimicrobial Agents and Chemotherapy|February 1, 1997
In vitro activity and spectrum of LY333328, a novel glycopeptide derivativeR N Jones, M S Barrett, M E Erwin
Diagnostic Microbiology and Infectious Disease|February 1, 1995
Emerging multiply resistant enterococci among clinical isolates. II. Validation of the etest to recognize glycopeptide-resistant strainsR N Jones, M E Erwin, S C Anderson
Pageof 95